BCG Tice

DRUG2 trials

Sponsors

Aeras, University of Oxford

Conditions

Tuberculosis

Phase 1

Study of AERAS 422 in Healthy Adults

CompletedNCT01340820

AerasTuberculosis

Start: 2010-12-31End: 2012-05-31Updated: 2012-08-16

Unknown Phase

A Clinical Challenge Study of BCG in Healthy Volunteers

CompletedNCT02088892

University of OxfordTuberculosis

Start: 2014-03-31End: 2015-01-31Updated: 2015-01-22

Related Papers

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.

2016-04-1952 citations

Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity

The Journal of Infectious Diseases2015-10-0834 citations